Search
Searching Content indexed under Food, Drugs, Healthcare, Life Sciences by Adriana Burgy ordered by Published Date Descending.
Links to Result pages
 
1  
 
Title
Country
Organisation
Author
Date
1
The Amazing Story Of The Unsinkable Claim 8: How Many Lives Does A Patent Claim Have?
Decision: Mylan Pharmaceuticals Inc. v. Research Corporation Technologies, Inc., 914 F.3d 1366 (Fed. Cir. 2019) (LOURIE, Bryson, Wallach)
United States
19 Jul 2019
2
Inherency And Obviousness
This case provides an example of the use of inherency in an obviousness determination. That is, the Northern District Court of Illinois found that claim 6 of U.S. Pat. 8,648,106 (the '106)
United States
7 Jan 2019
3
Myriad, Mayo, Chakrabarty, Oh My: Strategies For Life Sciences Diagnostics – Part III
In Part III of "Myriad, Mayo, Chakrabarty, Oh My: Strategies for Life Sciences Diagnostics", we consider the use of examiner interviews and how they can assist into obtaining allowable diagnostic claims.
United States
12 Apr 2017
4
Myriad, Mayo, Chakrabarty, Oh My: Strategies For Life Sciences Diagnostics – Part II
Often times, the number of claims that protect an invention is overlooked and not necessarily a discussion point when drafting a patent application.
United States
8 Mar 2017
5
Myriad, Mayo, Chakrabarty, Oh My: Strategies For Life Sciences Diagnostics - Part I
Patent eligibility is a balancing act; the Supreme Court explained in Mayo that "too broad an interpretation of this exclusionary principle could eviscerate patent law
United States
8 Mar 2017
6
The New Normal: Post-Grant Review Of Pharmaceutical Patents
AIA established post-grant proceedings in the U.S. Patent and Trademark Office (USPTO) that have emerged as a battleground for pharmaceutical patent challenges in addition to the usual district court venue.
United States
30 Jul 2015
Links to Result pages
 
1